2019-09-25
Comment on recent promotional activity
2019-03-28
Proteo’s Elafin Enters The Clinic For Subcutaneous Use In Pulmonary Arterial Hypertension
2019-02-25
Proteo Receives GLP Certificate From Competent Authority
2018-11-15
Proteo Announces Change in Leadership
2018-07-17
New mechanism of Elafin to prevent lung injury in mechanically ventilated newborns
2017-12-18
Further confirmation of Elafin’s potential to prevent oxygen-induced lung injury in mechanically ventilated newborns
2016-06-06
Proteo receives US$ 1 million grant for a new Elafin drug formulation
2015-03-12
Elafin combined with cyclosporine promises to overcome limitations of cyclosporine for preventing irreversible damage to transplanted organs
2014-12-05
Proteo Biotech AG expands Management Board
2014-11-21
Final Analysis of the Phase II Clinical Study on Elafin in coronary artery bypass surgery completed
